Rich Nations Seek to Gain Bulk of Future Covid-19 Vaccine - Study
A new global assessment of purchasing agreements for Covid-19 vaccines reveals that high-income countries, as well as a few middle-income countries flush with manufacturing capacity, have already purchased nearly 3.8 billion doses, with options for another five billion. The analysis, released by the Duke Global Health Innovation Center, shows that many of these countries will be able to vaccinate their entire populations-and some many times over-before billions of people are vaccinated in low-income countries. While other assessments have warned of potential inequalities in vaccine access, this new analysis is the first to carefully quantify the amount of vaccine doses that are being claimed by country-level agreements and how this could delay access to Covid-19 protection across large regions - including sub-Saharan Africa - until almost the middle of the decade.
InFocus
-
As of January 25, confirmed cases of Covid-19 from 55 African countries reached 3,437,638. Reported deaths in Africa reached 85,184 and 2,892,407 people have recovered.
Use ... Read more »
-
In Benin, the World Health Organisation (WHO) welcomed the nation's expansion of laboratory facilities for testing Covid-19, allowing it to perform 10,000 tests per day. Similarly, ... Read more »
-
The number of people who need critical care is increasing, from below 10 cases a few weeks ago to 18 patients in ICU, 49 on supplementary oxygen and 16 in the high dependency unit, ... Read more »
A medical scientist works on testing of the novel coronavirus.
